Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: A case-matched study

Transfusion

Volumn 55, Issue 12, 2015, Pages 2791-2798

  Guinn, Nicole R ^a   Roberson, Russell S ^c   White, William ^a   Cowper, Patricia A ^b   Broomer, Bob ^a   Milano, Carmelo ^a   Chiricolo, Antonio ^d   Hill, Steven ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; ERYTHROPOIETIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CASE STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEART SURGERY; HOSPITAL COST; HOSPITAL DISCHARGE; HUMAN; JEHOVAH'S WITNESS; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT; CASE CONTROL STUDY; COMPARATIVE STUDY; ECONOMICS; MIDDLE AGED; RETROSPECTIVE STUDY;

AGED; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; ERYTHROPOIETIN; HEALTH CARE COSTS; HEMOGLOBINS; HUMANS; JEHOVAH'S WITNESSES; LENGTH OF STAY; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84959534575     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13246     Document Type: Article

References (35)

1. Karkouti K, Wijeysundera DN, Beattie WS., Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008; 117: 478-84.
2. Murphy GJ, Reeves BC, Rogers CA, et al., Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-52.
3. Isbister JP, Shander A, Spahn DR, et al., Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev 2011; 25: 89-101.
4. Pedersen AB, Mehnert F, Overgaard S, et al., Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. BMC Musculoskelet Disord 2009; 10: 167.
5. Castillo JJ, Pascual SK., Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood 2010; 116: 2897-907.
6. Ferraris VA, Davenport DL, Saha SP, et al., Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147: 49-55.
7. Bilgin YM, van de Watering LM, Versteegh MI, et al., Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery. Transfusion 2011; 51: 2603-10.
8. Sarani B, Dunkman WJ, Dean L, et al., Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008; 36: 1114-8.
9. Rana R, Fernández-Pérez ER, Khan SA, et al., Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46: 1478-83.
10. Murphy GJ, Pike K, Rogers CA, et al., Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372: 997-1008.
11. Carson JL, Terrin ML, Noveck H, et al., Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62.
12. Villanueva C, Colomo A, Bosch A, et al., Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
13. Gombotz HR, Shander A, Hofmann A., Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 1468-80.
14. Jakobsen CJ, Tang M, Andreasen JJ, et al., Transfusion of blood during cardiac surgery is associated with higher long-term mortality in low-risk patients. Eur J Cardiothorac Surg 2012; 42: 114-20.
15. Khanna MP, Hébert PC, Fergusson DA., Review of the clinical practice literature on patient characteristics associated with perioperative allogeneic red blood cell transfusion. Transfus Med Rev 2003; 17: 110-9.
16. Van der Linden P, Dierick A,. Blood conservation strategies in cardiac surgery. Vox Sang 2007; 92: 103-12.
17. Spahn DR, Moch H, Hofmann A, et al., Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology 2008; 109: 951-3.
18. Kamat PV, Baker CB, Wilson JK, et al., Open-heart surgery in Jehovah's Witnesses: experience in a Canadian hospital. Ann Thorac Surg 1977; 23: 367-70.
19. Ott DA, Cooley DA., Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion. JAMA 1977; 238: 1256-8.
20. Sandiford FM., Aortocoronary bypass in Jehovah's Witnesses: review of 46 patients. Am Surg 1976; 42: 17-22.
21. Rosengart TK, DeBois WJ, Garcia N, et al., Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique. J Am Coll Surg 1997; 184: 618-29.
22. Montiglio F, Dor V, Lecompte J, et al., Cardiac surgery in adults and children without use of blood. Ann Thorac Cardiovasc Surg 1998; 4: 3-11.
23. McCartney S, Guinn N, Roberson R, et al., Jehovah's Witnesses and cardiac surgery: a single institution's experience. Transfusion 2014; 54: 2745-52.
24. Stamou SC, White T, Barnett S, et al., Comparisons of cardiac surgery outcomes in Jehovah's versus Non-Jehovah's Witnesses. Am J Cardiol 2006; 98: 1223-5.
25. Reyes G, Nuche JM, Sarraj A, et al., [Bloodless cardiac surgery in Jehovah's Witnesses: outcomes compared with a control group]. Rev Esp Cardiol 2007; 60: 727-31. Spanish.
26. Pattakos G, Koch CG, Brizzio ME, et al., Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med 2012; 172: 1154-60.
27. Frank SM, Wick EC, Dezern AE, et al., Risk-adjusted clinical outcomes in patients enrolled in a bloodless program. Transfusion 2014; 54: 2668-77.
28. Roques F, Michel P, Goldstone AR, et al., The logistic EuroSCORE. Eur Heart J 2003; 24: 881-2.
29. Lehmann EL., Nonparametrics: statistical methods based on ranks, revised. New York: Springer-Verlag; 1998.
30. Koch CG, Li L, Duncan AI, et al., Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: 1608-16.
31. Nolan JP, Mythen G., Hydroxyethyl starch: here today, gone tomorrow. Br J Anaesth 2013; 111: 321-4.
32. Shehata N, Forster A, Li L, et al., Does anemia impact hospital readmissions after coronary artery bypass surgery? Transfusion 2013; 53: 1688-97; quiz 7.
33. Lin RJ, Evans AT, Chused AE, et al., Anemia in general medical inpatients prolongs length of stay and increases 30-day unplanned readmission rate. South Med J 2013; 106: 316-20.
34. Donzé J, Aujesky D, Williams D, et al., Potentially avoidable 30-day hospital readmissions in medical patients: derivation and validation of a prediction model. JAMA Intern Med 2013; 173: 632-8.
35. Smith DM, Norton JA, McDonald CJ., Nonelective readmissions of medical patients. J Chronic Dis 1985; 38: 213-24.